Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Otol Neurotol ; 42(1): e10-e14, 2021 01.
Article in English | MEDLINE | ID: covidwho-966021

ABSTRACT

OBJECTIVE: To describe a case of bilateral sudden sensorineural hearing loss (SSNHL) and intralabyrinthine hemorrhage in a patient with COVID-19. STUDY DESIGN: Clinical capsule report. SETTING: Tertiary academic referral center. PATIENT: An adult woman with bilateral SSNHL, aural fullness, and vertigo with documented SARS-CoV-2 infection (IgG serology testing). INTERVENTIONS: High-dose oral prednisone with taper, intratympanic dexamethasone. MAIN OUTCOME MEASURES: Audiometric testing, MRI of the internal auditory canal with and without contrast. RESULTS: A patient presented with bilateral SSNHL, bilateral aural fullness, and vertigo. Serology testing performed several weeks after onset of symptoms was positive for IgG COVID-19 antibodies. MRI showed bilateral intralabyrinthine hemorrhage (left worse than right) and no tumor. The patient was treated with two courses of high-dose oral prednisone with taper and a left intratympanic dexamethasone injection, resulting in near-resolution of vestibular symptoms, a fluctuating sensorineural hearing loss in the right ear, and a severe to profound mixed hearing loss in the left ear. CONCLUSIONS: COVID-19 may have otologic manifestations including sudden SSNHL, aural fullness, vertigo, and intralabyrinthine hemorrhage.


Subject(s)
COVID-19/complications , Hearing Loss, Sensorineural/virology , Hemorrhage/virology , Labyrinth Diseases/virology , Adolescent , Anti-Inflammatory Agents/therapeutic use , Dexamethasone/administration & dosage , Female , Hearing Loss, Bilateral/virology , Hearing Loss, Sudden/virology , Humans , Injection, Intratympanic , Prednisone/therapeutic use , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL